期刊文献+

外阴皮肤和黏膜上皮非瘤样病变诊治现状 被引量:4

Current status of diagnosis and treatment of nonneoplastic epithelial disorders of the vulvar skin and mucosa
原文传递
导出
摘要 外阴皮肤和黏膜上皮非瘤样病变是指女性外阴皮肤和黏膜组织发生变性及色素改变的一组慢性疾病。目前认为自身免疫可能与硬化性苔藓发生关系密切;掌握早期和充分发展期硬化性苔藓的病理分类,有利于治疗时机的把握;超强效的糖皮质激素可用于治疗硬化性苔藓,是儿童硬化性苔藓治疗的一线药物;聚焦超声和中药等多种方法治疗均有效,但至今尚无一套公认的最佳治疗方案。 Nonneoplastic epithelial disorders of the vulvar skin and mucosa is a chronic mucocutaneous tissue degeneration and depigrnentation affecting vulvar skin and mucous. Abnormal autoimmunity may cause Lichen sclerosus (LS). LS was divided early stage and advanced stage in pathology, response to treatment was varied according to the stage of the lesions where better results were seen in the early stages. Ultrapotent topical corticosteroids are used for the treatment of LS, which are first line in children. Many treatments including Focused ultrasound and Chinese medicine are effective, but there are no the best method for treatment by now.
作者 武昕
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2009年第12期885-888,共4页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 外阴皮肤和黏膜上皮非瘤样病变 自身免疫性疾病 糖皮质激素 nonneoplastic epithelial disorders of the vulvar skin and mucosa autoimmune disease glueocortieoid
  • 相关文献

参考文献15

  • 1Oyama N, Chan I, Neill SM, et aL Autoantibodies to extracellular matrix protein 1[ in lichen sclerosus [ J ]. Lancet, 2003,362 : 118- 123.
  • 2Wenzel J, Wiechert A, Merkel C, et al. IP10/CXCL10 - CXCR3 interaction: a potential self-recruiting mechanism for cytotoxic lymphocytes in lichen sclerosus et atrophicus [ J ]. Acta Derm Venereol, 2007,87 : 112 - 117.
  • 3Farrell AM, Dean D, Millard PR,et al. Cytokine alterations in lichen sclerosus : an immunohistochemical study [ J ]. Br J Dermatol,2006,155 : 931-940.
  • 4Friedrich EG Jr,Kalra PS. Serum leverl of sex homones in vulval lichen selerosus and the effect of topical testosterone[J]. N Engl J Med, 1984,310:488-491.
  • 5Xing HG, Bamardo M, Winsey S, et al. The association between HLA DR, DQ antigen, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/ 010haploytpe confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated DRB10301/04/ DRB10210/02/03haplotype protects from vulval lichen sclerosus [ J ]. Invest Dermatol,2005,125 : 895-899.
  • 6Sander CS, Ali I, Dean D,et al. Oxidative stress is implicated in the pathogenesis of lichen sclerosus [ J ]. Br J Dermatol, 2004, 151:627-635.
  • 7Regauer S, Liegl B, Reich O. Early vulvar lichen sclerosus: a histopathological challenge [ J ]. Histopathology, 2005,47: 340- 347.
  • 8Diakomanolis ES, Haidopoulos D, Syndos M. Vulvar lichen sclemsus in postmenopausal women: a comparative study for treating advanced disease with clobetasol propionate 0. 05% [ J]. Eur J Gynaecol Oncol,2002,23 : 519 -522.
  • 9Smith YR, Quint EH. Clobetasol propionate in the treatment of premenarchal vulvar lichen sclerosus [ J ]. Obstet Gynecol, 2001,98(4) :588-591.
  • 10Ayhan A,Guven S, Guvendag Guven ES, et al. Topical testosterone versus clobetasol for vulvar lichen sclerosus [ J ]. Int J Gynaecol Obstet,2007,96 : 117-121.

二级参考文献1

共引文献84

同被引文献27

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部